Harvard Bioscience
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $20,450 | $21,774 | $24,556 | $21,970 |
Gross Profit | 10,371 | 12,184 | 14,011 | 12,765 |
EBITDA | 155 | -48,337 | 3,203 | -1,820 |
EBIT | -1,463 | -49,992 | 1,443 | -3,635 |
Net Income | -2,282 | -50,340 | 18 | -4,802 |
Net Change In Cash | 20,450 | 21,774 | 24,556 | 21,970 |
Free Cash Flow | 2,522 | 2,473 | 1,424 | -1,499 |
Cash | 7,442 | 5,546 | 4,108 | 4,569 |
Basic Shares | 44,303 | 44,096 | 43,538 | 43,614 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $94,135 | $112,250 | $113,335 | $118,904 |
Gross Profit | 54,766 | 66,071 | 60,819 | 67,652 |
EBITDA | -1,474 | 8,033 | 944 | 11,311 |
EBIT | -8,456 | 1,035 | -6,631 | 3,690 |
Net Income | -12,405 | -3,415 | -9,516 | -288 |
Net Change In Cash | 94,135 | 112,250 | 113,335 | 118,904 |
Cost of Revenue | -3,275 | -335 | ||
Free Cash Flow | -1,204 | 11,717 | -438 | -83 |
Cash | 4,108 | 4,283 | 4,508 | 7,821 |
Basic Shares | 43,538 | 42,420 | 41,413 | 40,343 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.01 |
2025-03-31 | -$0.01 |
2024-12-31 | $0.06 |
